15 Apr 2017

UK Department of Health Has Neither Requested Nor Received Any Advice On Medicinal Cannabis.

This is the astonishing reality of the way the UK government is responding to the national outcry for access to cannabis as medicine. They are doing absolutely nothing. Across the world a revolution is taking place as more and more jurisdictions are introducing legal access to medical cannabis. Medical professionals and patients alike are realising the huge benefits to be gained from re-opening access to this most valuable of...

17 Mar 2017

How To Campaign For Cannabis Law Reform Under A Theresa May Government.

    + Lobbying Parliament   + If the Government Won't Regulate Cannabis Then We'll Do It For Them   + The CBD Market   + Medical Cannabis   + Educating And Influencing Researchers   For cannabis and drugs policy reform, out of 650 MPs, there could not have been a worse person to seize power than Theresa May.  There are a few who come close on both Tory and Labour benches but no one who has such a long record of bigotry, denial of evidence and refusal even to consider the subject. [caption id="attachment_7621"...

31 Jan 2017

The UK Government’s Very Last Excuse For Denying Access To Medicinal Cannabis.

Essentially, UK government policy on cannabis hasn't altered since 1971.  Despite the vast amount of new evidence published since then and revolutionary change, particularly on medicinal use, all across the world, successive governments have stubbornly and obstinately refused to consider any sort of reform. It doesn't matter which party has been in power, Conservative, Labour or the coalition, it's a subject that ministers and MPs simply refuse to engage with.  It's easier that way for them and be in no doubt: laziness,...

06 Dec 2016

The Facts About CBD In The UK. December 2016.

On 3rd October 2016 the Medicines and Healthcare products Regulatory Agency (MHRA)  issued notices to a number of CBD suppliers stating that cannabidiol (CBD) was being designated as a medicine and that sale of all CBD products must stop within 28 days, ostensibly by the 1st November. A lot has happened since.  Most importantly, the Cannabis Trades Association UK (CTAUK) has been established to represent the industry and protect the interests of CBD consumers but there remains great confusion as to the legal status of CBD...

23 Nov 2016

Crispin Blunt Asks Parliamentary Question On Medicinal Cannabis, 22nd November 2016.

Q. To ask the Secretary of State for Health, whether (a) his Department and (b) the Medicine and Healthcare Products Regulatory Agency has reviewed the latest evidence, including evidence on different regulatory approaches in other jurisdictions, for the use of medical cannabis. A. The Medicines and Healthcare products Regulatory Agency (MHRA) reviews evidence submitted by a company seeking a marketing authorisation for a medicinal...

17 Nov 2016

Cruel And Irresponsible Response from UK Government To Parliamentary Report On Medicinal Cannabis.

Unsurprisingly perhaps, the response to the recent call from MPs and peers to legalise cannabis for medicinal use has come straight from the top.  Theresa May's longstanding reputation as a denier of science and evidence on drugs policy is reinforced by her peremptory dismissal of the expert report.  It seems that, at least in the short term, the UK government is sticking by a policy that is discredited, ridiculous and deeply cruel. It fell to Sarah Newton MP, minister of state...

15 Oct 2016

The British Medical Journal (BMJ) Features The CLEAR Medicinal Cannabis Campaign.

"Muddled thinking" over cannabis leaves patients in limbo, warn campaigners BMJ 2016; 355 doi: http://dx.doi.org/10.1136/bmj.i5556 (Published 14 October 2016) Cite this as: BMJ 2016;355:i5556 Download PDF here Companies selling cannabis based products have been told to remove them from the market within 28 days, after a review by the Medicines and Healthcare Products Regulatory Agency (MHRA) determined that they were medicinal products. Campaigners for cannabis law reform welcomed the recognition that cannabidiol (CBD) had medicinal properties but warned that...

12 Oct 2016

The Man From The MHRA. Endangering Public Health With Precipitate Action On CBD.

The Medicines and Healthcare Products Regulatory Agency (MHRA) apparent decision to designate cannabidiol (CBD) as a medicine is an unholy mess and has been handled about as badly as it is possible for a government agency to deal with a matter of public safety. The desk of Dr Ian Hudson, the Chief Executive, will shortly be groaning under the weight of correspondence from MPs asking him to explain exactly what is going on.  We know that...

07 Oct 2016

Professor Mike Barnes Speaks Out On the CBD Ban.

Professor Mike Barnes, neurologist, scientific and medical advisor to CLEAR Cannabis Law Reform, has issued the following statement. "It is encouraging that the MRHA is recognising that CBD has medicinal value but it is concerning that many people benefitting from CBD now will suffer in the short term as good quality manufacturers have to stop production pending MRHA approval"  A redacted copy of the letter now being sent to all CBD...

17 Sep 2016

CLEAR’s Submission To The Parliamentary Inquiry Into Medicinal Cannabis.

This was the response that CLEAR submitted to the APPG in February 2016.  In March 2016, Roland Gyallay-Pap, then managing director of CLEAR and Peter Reynolds, president, were called to give oral evidence to the Inquiry. A PDF copy of this document may be downloaded here. A copy of the Powerpoint presentation delivered by CLEAR at the oral evidence hearing can be downloaded here.   Introduction In June 2015 the All-Party Parliamentary Group for Drug Policy Reform (APPG) published a short report arguing for a rescheduling of...